A
Andrea L. Cheville
Researcher at Mayo Clinic
Publications - 179
Citations - 7718
Andrea L. Cheville is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Cancer & Breast cancer. The author has an hindex of 41, co-authored 154 publications receiving 5996 citations. Previous affiliations of Andrea L. Cheville include University of Pennsylvania.
Papers
More filters
Journal ArticleDOI
Breast Cancer-Related Lymphedema Risk is Related to Multidisciplinary Treatment and Not Surgery Alone: Results from a Large Cohort Study.
TL;DR: BCRL is a sequelae of multimodal breast cancer treatment and risk is multifactorial, higher in patients receiving chemotherapy, radiation, ALND, more advanced disease stage, and higher body mass index.
Journal ArticleDOI
Cancer Rehabilitation: An Overview of Current Need, Delivery Models, and Levels of Care
Andrea L. Cheville,Karen M. Mustian,Kerri M. Winters-Stone,David S. Zucker,Gail L. Gamble,Catherine M. Alfano +5 more
TL;DR: Criteria for determining a survivor's needs across this spectrum of cancer rehabilitation programs are proposed, and the role of the physiatrist as a vital advocate and champion discussed.
Journal ArticleDOI
Effect of Collaborative Telerehabilitation on Functional Impairment and Pain Among Patients With Advanced-Stage Cancer: A Randomized Clinical Trial.
TL;DR: Collaborative telerehabilitation modestly improved function and pain, while decreasing hospital length of stay and the requirement for postacute care, but these outcomes were not enhanced with the addition of pharmacological pain management.
Journal ArticleDOI
Randomized controlled trial of maintaining quality of life during radiotherapy for advanced cancer.
Matthew M. Clark,Teresa A. Rummans,Pamela J. Atherton,Andrea L. Cheville,Mary E. Johnson,Marlene H. Frost,Janis J. Miller,Jeff A. Sloan,Karen M. Graszer,Jean G. Haas,Jean M. Hanson,Yolanda I. Garces,Katherine M. Piderman,Maria I. Lapid,Pamela J. Netzel,Jarrett W. Richardson,Paul D. Brown +16 more
TL;DR: Psychosocial interventions often address only 1 domain of quality of life (QOL), are offered to patients with early‐stage cancer, do not include the caregiver, and are delivered after cancer treatment has been completed.
Journal ArticleDOI
Pilot evaluation of Scrambler therapy for the treatment of chemotherapy-induced peripheral neuropathy
Deirdre R. Pachman,Breanna L. Weisbrod,Drew K. Seisler,Debra L. Barton,Kelliann C. Fee-Schroeder,Thomas J. Smith,Daniel H. Lachance,Heshan Liu,Randy A. Shelerud,Andrea L. Cheville,Charles L. Loprinzi +10 more
TL;DR: Preliminary data support that Scrambler therapy may be effective for the treatment of CIPN: a prospective placebo-controlled clinical trial should be performed.